Dynocardia

Lowell, MA · Founded 2015 · Privately Held (backing)

Developer of a wearable blood pressure monitoring device designed to accurately and continuously measure blood pressure. Dynocardia is based in Lowell, MA and was founded in 2015. Its last reported valuation was $12.5 million in Jan 2021. It has raised $8.3 million across 4 recorded rounds; the latest was a $1.2 million seed round in Mar 2025.

Last reported valuation
$12.5M
Oct 2026
Priced at
—
Total raised
$8.3M
Last round
Seed Round
Mar 2025
Cap table — not yet on record

Dynocardia's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Dynocardia with a free account
  • ·The complete investor list: 11 names
  • ·Watch Dynocardia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Dynocardia

Where does Dynocardia's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Dynocardia's 4 recorded funding rounds.